Results 11 to 20 of about 5,335 (299)

Coronary Artery Disease Risk and Lipidomic Profiles Are Similar in Hyperlipidemias With Family History and Population‐Ascertained Hyperlipidemias [PDF]

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background We asked whether, after excluding familial hypercholesterolemia, individuals with high low‐density lipoprotein cholesterol (LDL‐C) or triacylglyceride levels and a family history of the same hyperlipidemia have greater coronary artery disease ...
Joel T. Rämö, Pietari Ripatti, Rubina Tabassum, Sanni Söderlund, Niina Matikainen, Mathias J. Gerl, Christian Klose, Michal A. Surma, Nathan O. Stitziel, Aki S. Havulinna, Matti Pirinen, Veikko Salomaa, Nelson B. Freimer, Matti Jauhiainen, Aarno Palotie, Marja‐Riitta Taskinen, Kai Simons, Samuli Ripatti   +17 more
doaj   +2 more sources

Secondary hyperlipidemias: etiology and pathogenesis

Российский кардиологический журнал, 2019
In accordance with modern clinical guidelines, the main aim of therapy for cardiovascular risk reducing is achievement of target level of lipid parameters.
A. I. Ershova, D. O. Al Rashi, A. A. Ivanova, Yu. O. Aksenova, A. N. Meshkov   +4 more
doaj   +2 more sources

Hyperlipidemias in elderly patients: results from the Berlin Aging Study II (BASEII), a cross-sectional study [PDF]

Lipids in Health and Disease, 2020
Background Hyperlipidemias are common and the last decades have seen substantially growing evidence of their causative role in the development of atherosclerosis and subsequent cardiovascular diseases.
Adrian Rosada, Ursula Kassner, Felix Weidemann, Maximilian König, Nikolaus Buchmann, Elisabeth Steinhagen-Thiessen, Dominik Spira   +6 more
doaj   +2 more sources

APPROACHES TO THE LIPID METABOLISM GENES POLYMORPHYSM ANALYSIS IN SCREENING FOR ATHEROSCLEROSIS RISK FACTORS

Российский кардиологический журнал, 2014
The review concerns he etiology of polygenic hyperlipidemias. The most prominent and prevalent in more than 1% of inhabitants genetic markers are discussed.
N. V. Koch, G. I. Lifschitz, E. N. Voronina   +2 more
doaj   +3 more sources

Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low‐Density Lipoprotein Receptor Expression

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Background The pathways of diastolic dysfunction and heart failure with preserved ejection fraction driven by lipotoxicity with metabolic syndrome are incompletely understood.
Monique Williams, Jose Manuel Condor Capcha, Camila Iansen Irion, Grace Seo, Guerline Lambert, Ali Kamiar, Keyvan Yousefi, Rosemeire Kanashiro‐Takeuchi, Lauro Takeuchi, Ali G. Saad, Armando Mendez, Keith A. Webster, Jeffrey J. Goldberger, Joshua M. Hare, Lina A. Shehadeh   +14 more
doaj   +1 more source

Rationale, Design, and Initial Findings of Community Trial on Improving the Iranian’s Knowledge and Practice of Dyslipidemia Management, Prevention, and Control [PDF]

ARYA Atherosclerosis, 2022
BACKGROUND: To investigate the effects of comprehensive, integrated interventions on dyslipidemia Knowledge and Practices (LIPOKAP) using population and high-risk approaches.METHODS: The baseline of this national, multicentric community trial was ...
Noushin Mohammadifard, Maryam Maghroun, Marzieh Taheri, Marjan Mansourian, Farid Najafi, Hossein Farshidi, Tooba Kazemi, Masoud Lotfizadeh, Kamal Solati, Ali Pourmoghaddas, Hassan Alikhasi, Jamshid Najafian, Masoumeh Sadeghi, Katayoun Rabiei, Hamidreza Roohafza, Mahammadreza Sabri, Nizal Sarrafzadegan   +16 more
doaj   +1 more source

Hyperlipidemic pancreatitis in children: characteristics of the course and a clinical case presentation

Zaporožskij Medicinskij Žurnal, 2022
The article presents data on the prevalence, clinical, diagnostic and treatment characteristics of acute hyperlipidemic pancreatitis in children, based on a literature review and a clinical case presentation.
I. S. Lembryk, O. O. Tsytsiura, O. V. Zhyliak, O. V. Dutchuk, P. Z. Buiak, Н. M. Dutchak, I. Y. Krasivskyi   +6 more
doaj   +1 more source

Antihyperlipidemic and Antioxidant Effects of Ethanol Fraction of Sargassum angustifolium in Dexamethasone-Induced Dyslipidemic Rats [PDF]

Research Journal of Pharmacognosy, 2022
Background and objectives: Recent data propose the beneficial antihyperlipidemic effects of several marine brown alga belonging to the genus Sargassum.
Afsaneh Yegdaneh, Leila Safaeian*, Mahnaz Halvaei-Varnousfaderani, Saeed Bazvand   +3 more
doaj   +1 more source

The changes in cardiovascular disease risk factors after the implementation of the package of essential non-communicable disease control [PDF]

Journal of Cardiovascular and Thoracic Research
Introduction: The Package of Essential Non-Communicable (PEN) Disease Control was implemented in the primary healthcare system to manage cardiovascular disease (CVD) risk factors in Iran. This study aimed to evaluate the status of CVD risk factor control
Ali Reza Pouramini, Fatemeh Kafi, Reza Khadivi   +2 more
doaj   +1 more source

Adding ezetimibe to statin therapy: latest evidence and clinical implications

Drugs in Context, 2018
Background: Statins are the hypolipemic treatment of choice for hyperlipidemia with confirmed atherosclerotic cardiovascular disease (ASCVD) protective effect, proven even in normolipemic patients.
Marija Vavlukis, Ana Vavlukis
doaj   +1 more source